| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |